Jeffrey Collins

Institute for Molecular Medicine

Papers

1

Total Citations

28

H-Index

1

About

Jeffrey Collins is a leading figure in radiochemistry and automation, whose work has significantly advanced the field of positron emission tomography (PET) tracer production. His primary research focuses on developing novel, fully automated radiosynthesizers that enable the safe, reproducible, and high-yield production of diverse PET tracers. Collins’s most notable contribution is the design and validation of the ELIXYS system, a three-reactor, high-pressure synthesizer that streamlines both development and routine clinical production. This work, detailed in his highly cited 2013 paper (28 citations), directly addresses the critical need to minimize operator radiation exposure while ensuring consistent synthesis quality. By moving beyond single-use disposable kits toward a more flexible, multi-reactor platform, Collins has provided the radiochemistry community with a powerful tool for expanding the range of tracers available for clinical and research applications. His innovations are foundational for labs seeking to accelerate the translation of novel imaging agents from bench to bedside, cementing his reputation as a key enabler of modern molecular imaging.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
ELIXYS - a fully automated, three-reactor high-pressure radiosynthesizer for development and routine production of diverse PET tracers
28 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Institute for Molecular Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago